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The development of next-generation sequencing (NGS)
technology opens new avenues for clinical researchers to
make discoveries, especially in the area of clinical diag-
nostics. However, combining NGS and clinical data pre-
sents two challenges: first, the accessibility to clinicians
of sufficient computing power needed for the analysis of
high volume of NGS data; and second, the stringent
requirements of accuracy and patient information data
governance in a clinical setting.
Cloud computing is a natural fit for addressing the
computing power requirements, while Clinical Labora-
tory Improvement Amendments (CLIA) certification
provides a baseline standard for meeting the demands on
researchers in working with clinical data. Combining a
cloud-computing environment with CLIA certification
presents its own challenges due to the level of control
users have over the cloud environment and CLIA’s stabi-
lity requirements. We have bridged this gap by creating a
locked virtual machine with a pre-defined and validated
set of workflows. This virtual machine is created using
our Galaxy VM launcher tool to instantiate a Galaxy
[http://www.usegalaxy.org] environment at Amazon with
specific versions of the tools used in the workflow. The
VM launcher tool can reliably recreate the same virtual
machine on several cloud environments. Once a baseline
virtual machine is created, the tool can launch any num-
ber of clones to analyze samples in parallel. We describe
herein a pilot project as an example of a working clinical
analysis pipeline. In order to validate the clinical diagno-
sis of diseases with a genetic cause using NGS data,
patient samples were collected by Dr Bharat Thyagarajan
and staff at the Molecular Diagnostics Laboratory,
University of Minnesota medical center-Fairview. The
patient samples were analyzed using customized hybrid-
capture bait libraries to boost read coverage in low-
coverage regions, followed by targeted enrichment
sequencing at the BioMedical Genomics Center. The
NGS data is imported to a tested Galaxy single nucleo-
tide polymorphism (SNP) detection workflow in a locked
Galaxy virtual machine on Amazon’s Elastic Compute
Cloud (EC2). This project illustrates our ability to carry
out CLIA-certified NGS analysis in the cloud, and will
provide valuable guidance in any future implementation
of NGS analysis involving clinical diagnosis.
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